To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BTN3A2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
377 representative clones for gene BTN3A2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CV326754 testis_normal .a 1 to 116 1 to 121   tiling clone,   121/121
(100 %)
5 diff
(95.9 %id)
BM712980 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 104 to 474 1 to 371   tiling clone, to resequence,   371/371
(100 %)
0 diff
(100 %id)
BM676164 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1263 to 1907 642 to 1   tiling clone, to resequence,   642/642
(100 %)
4 diff
(99.4 %id)
BQ776837 Pancreas, Purified pancreatic islet .b 1 to 559 1 to 559   tiling clone,   559/560
(99 %)
3 diff
(99.5 %id)
DA547948   .b 3 to 558 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BI823694 pooled brain, lung, testis .b 33 to 785 1 to 752   tiling clone,   752/752
(100 %)
4 diff
(99.5 %id)
TI_57202469   .b 34 to 785 33 to 783       751/783
(95 %)
11 diff
(98.6 %id)
DA382251 thalamus .b 36 to 603 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BM808719 amelanotic melanoma, cell line, skin .b 604 to 1481 926 to 40   tiling clone, AAA Submitted on the opposite strand 887/1045
(84 %)
21 diff
(98.0 %id)
BQ776521 Pancreas, Purified pancreatic islet .b 1062 to 1650 589 to 1   tiling clone,   589/589
(100 %)
0 diff
(100 %id)
BX383871   .c 1 to 889 1 to 890   tiling clone,   890/890
(100 %)
3 diff
(99.7 %id)
CR626326 Placenta Cot 25-normalized .c 69 to 1562 1 to 1494 exact tiling clone,   1494/1494
(100 %)
0 diff
(100 %id)
BX356662 Placenta Cot 25-normalized .c 69 to 967 1 to 894   fully sequenced,   894/894
(100 %)
1 diff
(99.9 %id)
TI_154040269   .c 861 to 1596 861 to 137   AAA   725/886
(81 %)
34 diff
(96.2 %id)
BX356661 Placenta Cot 25-normalized .c 906 to 1562 656 to 1   fully sequenced,   656/656
(100 %)
4 diff
(99.4 %id)
BQ002512 Chondrosarcoma, Left Pelvis .c 910 to 1596 705 to 19   tiling clone, AAA   687/687
(100 %)
0 diff
(100 %id)
BX374070   .c 1016 to 1581 576 to 8       569/662
(85 %)
22 diff
(96.7 %id)
AW028256 thymus, pooled .c 1098 to 1603 507 to 3   tiling clone,   505/507
(99 %)
1 diff
(99.9 %id)
AK290880   .d 1 to 1460 1 to 1460 A182T N186D tiling clone,   1460/1460
(100 %)
3 diff
(99.8 %id)
DA655773   .d 2 to 563 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BF839207 head_neck .d 1258 to 1683 425 to 1     Submitted on the opposite strand 425/425
(100 %)
2 diff
(99.6 %id)
BF839307 head_neck .d 1258 to 1683 425 to 1     Submitted on the opposite strand 425/425
(100 %)
2 diff
(99.6 %id)
BM990718 lung, Lung Focal Fibrosis .d 1308 to 1956 650 to 1   tiling clone,   650/656
(99 %)
7 diff
(99.0 %id)
BE243465 leukopheresis .d 1394 to 1765 372 to 1       372/372
(100 %)
0 diff
(100 %id)
AI973228 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1410 to 1773 364 to 1   tiling clone,   364/364
(100 %)
0 diff
(100 %id)
AI473487 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1489 to 1773 286 to 1       286/286
(100 %)
1 diff
(99.7 %id)
DB101483 thymus .e 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
DA869526 Prostate .e 18 to 552 2 to 536   capped   535/535
(100 %)
3 diff
(99.5 %id)
AF257505   .e 107 to 1371 1 to 1265 S180G R211K G212S tiling clone,   1265/1265
(100 %)
9 diff
(99.3 %id)
BI012497 lung_normal .e 1145 to 1756 623 to 15       609/623
(97 %)
0 diff
(100 %id)
AW390797 stomach .e 1153 to 1760 1 to 607       607/613
(99 %)
10 diff
(98.4 %id)
U90143   .e 1164 to 2942 1 to 1777   tiling clone,   1777/1777
(100 %)
11 diff
(99.4 %id)
BE870332 adenocarcinoma, colon .e 1168 to 1923 1 to 756       756/930
(81 %)
18 diff
(98.1 %id)
AW379009 head_neck .e 1277 to 1764 490 to 1       490/490
(100 %)
16 diff
(96.8 %id)
BF663468 B-cells, primary B-cells from tonsils (cell line) .e 1333 to 2052 1 to 715       715/923
(77 %)
34 diff
(96.4 %id)
BG539538 lung .e 1361 to 1932 1 to 570       570/885
(64 %)
10 diff
(98.9 %id)
BF818432.
matches multiple genes
colon_ins .e 1371 to 1477 108 to 4     Submitted on the opposite strand, also hits gene BTN3A3andBTN2A1 105/108
(97 %)
0 diff
(100 %id)
BU195881 melanotic melanoma, cell line, skin .e 1385 to 2054 75 to 748       674/1067
(63 %)
26 diff
(97.6 %id)
BU179186 melanotic melanoma, cell line, skin .e 1390 to 2285 1 to 905       905/910
(99 %)
17 diff
(98.2 %id)
BQ682880 melanotic melanoma, cell line, skin .e 1390 to 2048 1 to 665       665/942
(70 %)
8 diff
(99.2 %id)
BQ683550 melanotic melanoma, cell line, skin .e 1393 to 2174 1 to 784       784/861
(91 %)
8 diff
(99.1 %id)
CB120907 Liver .e 1419 to 1768 1 to 350       350/350
(100 %)
1 diff
(99.8 %id)
BG331525 large cell carcinoma, lung .e 1424 to 2046 1 to 629       629/1143
(55 %)
24 diff
(98.0 %id)
CD356481 Blood vessels - aorta, basilar and artery .e 1458 to 2213 1 to 758       758/760
(99 %)
5 diff
(99.4 %id)
BI036392 nervous_tumor .e 1479 to 1908 440 to 11       430/440
(97 %)
0 diff
(100 %id)
CB158566 Liver .e 1505 to 2034 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BE393662 endometrium, adenocarcinoma cell line, uterus .e 1511 to 2098 1 to 601       601/604
(99 %)
19 diff
(96.9 %id)
AW368001 head_neck .e 1545 to 2047 1 to 503       503/503
(100 %)
0 diff
(100 %id)
CX872781 embryonic stem .e 1556 to 2374 1 to 819       819/819
(100 %)
1 diff
(99.9 %id)
BE156320 head_neck .e 1615 to 1885 279 to 10     Submitted on the opposite strand 270/279
(96 %)
0 diff
(100 %id)
BG323253 Kidney, renal cell adenocarcinoma .e 1738 to 2472 1 to 733       733/735
(99 %)
12 diff
(98.4 %id)
BQ671893 epidermoid carcinoma, cell line, salivary gland .e 1757 to 2476 1 to 721       721/934
(77 %)
15 diff
(98.4 %id)
BQ668427 epidermoid carcinoma, cell line, salivary gland .e 1757 to 2603 1 to 850       850/925
(91 %)
28 diff
(97.0 %id)
BQ674105 epidermoid carcinoma, cell line, salivary gland .e 1757 to 2603 1 to 863       863/978
(88 %)
33 diff
(96.7 %id)
BF793961 adrenal cortex carcinoma, cell line, adrenal gland .e 1803 to 2626 1 to 814       814/942
(86 %)
32 diff
(96.7 %id)
BF794034 adrenal cortex carcinoma, cell line, adrenal gland .e 1803 to 2644 1 to 838       838/856
(97 %)
26 diff
(97.0 %id)
AW378529 head_neck .e 1805 to 2409 23 to 627       605/628
(96 %)
10 diff
(98.5 %id)
W01774 multiple sclerosis lesions .e 1809 to 2205 1 to 395       395/401
(98 %)
3 diff
(99.3 %id)
R55938 whole brain .e 1866 to 2265 1 to 408       408/416
(98 %)
17 diff
(96.0 %id)
AA310176   .e 1869 to 2285 1 to 417       417/417
(100 %)
1 diff
(99.8 %id)
BM831724 stomach .e 1965 to 2516 1 to 552       552/552
(100 %)
0 diff
(100 %id)
BM822876 stomach .e 1966 to 2534 1 to 568       568/568
(100 %)
3 diff
(99.5 %id)
TI_151780091   .e 1980 to 2539 101 to 662       562/694
(80 %)
23 diff
(96.7 %id)
TI_149287465   .e 1987 to 2932 983 to 53   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 931/1157
(80 %)
42 diff
(96.4 %id)
CB956939 Pooled-Glandular .e 2001 to 2729 1 to 737   tiling clone,   737/742
(99 %)
11 diff
(98.6 %id)
W69537 heart .e 2020 to 2459 1 to 440   fully sequenced,   440/440
(100 %)
1 diff
(99.8 %id)
W25650 heart .e 2051 to 2559 1 to 517   fully sequenced,   517/517
(100 %)
8 diff
(98.5 %id)
T90138 lung .e 2077 to 2384 1 to 312       312/312
(100 %)
4 diff
(98.8 %id)
CB131853 Liver .e 2083 to 2599 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
BF882131 lung_tumor .e 2099 to 2506 541 to 134     Submitted on the opposite strand 408/542
(75 %)
0 diff
(100 %id)
AA482308 lung .e 2135 to 2540 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
BQ009036 Chondrosarcoma, Left Pelvis .e 2158 to 2932 792 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 774/774
(100 %)
3 diff
(99.7 %id)
CA431384 cell lines, Enchondroma .e 2160 to 2934 793 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 775/775
(100 %)
1 diff
(99.9 %id)
BI850697 lymph, lymphoma, cell line .e 2240 to 2869 1 to 631       631/631
(100 %)
2 diff
(99.7 %id)
BU589916 mixed (pool of 40 RNAs) .e 2256 to 2934 1 to 679       679/702
(96 %)
1 diff
(99.9 %id)
BQ447159 Knee, Osteoarthritic Cartilage .e 2266 to 2935 691 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 673/673
(100 %)
5 diff
(99.3 %id)
BM989822 lung, Lung Focal Fibrosis .e 2267 to 2932 679 to 15   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 665/665
(100 %)
2 diff
(99.7 %id)
BQ021763 lung, Metastatic Chondrosarcoma .e 2279 to 2935 674 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 656/656
(100 %)
1 diff
(99.9 %id)
BM972781 lung .e 2313 to 2932 638 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
AW800548 uterus .e 2315 to 2606 302 to 9       294/309
(95 %)
0 diff
(100 %id)
TI_149307027   .e 2338 to 2935 682 to 85   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 598/918
(65 %)
5 diff
(99.5 %id)
BM978964 lung, Primary Lung Epithelial Cells .e 2338 to 2935 616 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 598/599
(99 %)
5 diff
(99.2 %id)
BM932041 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 2348 to 2942 1 to 595       595/601
(99 %)
5 diff
(99.2 %id)
AI991252 colon, colonic mucosa from 3 patients with Crohn'sdisease .e 2365 to 2932 572 to 4       569/572
(99 %)
0 diff
(100 %id)
W78021 heart .e 2374 to 2828 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
W80868 heart .e 2397 to 2673 1 to 277   fully sequenced,   277/277
(100 %)
1 diff
(99.7 %id)
BE858415 brain, glioblastoma (pooled) .e 2404 to 2936 533 to 1       533/533
(100 %)
0 diff
(100 %id)
AA526914 breast .e 2414 to 2935 534 to 30   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 505/514
(98 %)
25 diff
(95.2 %id)
AA565010 normal prostate, Prostate .e 2429 to 2943 515 to 1   tiling clone,   515/515
(100 %)
0 diff
(100 %id)
AI401221 brain, glioblastoma (pooled) .e 2432 to 2935 504 to 1       504/504
(100 %)
0 diff
(100 %id)
AI123880 heart .e 2447 to 2932 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AI799899 Prostate .e 2451 to 2936 487 to 2       486/487
(99 %)
0 diff
(100 %id)
W69453 heart .e 2455 to 2931 478 to 1   fully sequenced,   478/478
(100 %)
2 diff
(99.6 %id)
AI817293.
matches multiple genes
normal prostate, Prostate .e 2456 to 2943 492 to 1     also hits gene BTN3A3andBTN2A1 492/492
(100 %)
27 diff
(94.6 %id)
AW083380 colon, moderately differentiated adenocarcinoma .e 2457 to 2824 369 to 1       369/369
(100 %)
1 diff
(99.8 %id)
AI499281 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 2465 to 2824 360 to 1       360/360
(100 %)
0 diff
(100 %id)
AA705211 liver and spleen .e 2471 to 2935 465 to 1       465/465
(100 %)
1 diff
(99.8 %id)
BG236481 blood, lymphocyte .e 2475 to 2936 463 to 2       462/463
(99 %)
0 diff
(100 %id)
AW264007 brain, three pooled meningiomas .e 2478 to 2824 347 to 1       347/347
(100 %)
2 diff
(99.5 %id)
AI927603 normal prostate, Prostate .e 2482 to 2935 454 to 1       454/534
(85 %)
0 diff
(100 %id)
AI223863 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2486 to 2936 452 to 2       451/452
(99 %)
0 diff
(100 %id)
AA643736 colon, colon tumor RER+ .e 2493 to 2932 442 to 4       439/442
(99 %)
0 diff
(100 %id)
BU740946 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 2494 to 2935 460 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 442/442
(100 %)
3 diff
(99.4 %id)
BQ026893 Chondrosarcoma, Left Pelvis .e 2497 to 2941 463 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 445/445
(100 %)
6 diff
(98.7 %id)
W81326 heart .e 2498 to 2935 1 to 437   fully sequenced,   437/437
(100 %)
2 diff
(99.6 %id)
BQ010674 placenta .e 2498 to 2935 455 to 18   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 438/438
(100 %)
4 diff
(99.1 %id)
AI278252 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2503 to 2931 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
CB109058 Liver .e 2504 to 2935 1 to 432   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 432/432
(100 %)
1 diff
(99.8 %id)
AA676830 liver and spleen .e 2506 to 2942 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
BQ019572 Chondrosarcoma, Left Pubic Bone .e 2508 to 2932 443 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 425/425
(100 %)
0 diff
(100 %id)
AW188972 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 2509 to 2824 317 to 1       317/317
(100 %)
1 diff
(99.7 %id)
N63022 multiple sclerosis lesions .e 2511 to 2936 441 to 1       441/510
(86 %)
24 diff
(95.3 %id)
AI127561 uterus .e 2513 to 2932 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AI805263 B-cell, chronic lymphotic leukemia .e 2513 to 2931 419 to 1       419/419
(100 %)
0 diff
(100 %id)
R55939 whole brain .e 2514 to 2930 429 to 7       423/431
(98 %)
0 diff
(100 %id)
AA878508 2 pooled tumors (clear cell type), Kidney .e 2514 to 2936 424 to 3       422/424
(99 %)
0 diff
(100 %id)
AI299603 carcinoid, lung .e 2514 to 2935 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AI301016 2 pooled tumors (clear cell type), Kidney .e 2514 to 2932 422 to 4       419/422
(99 %)
0 diff
(100 %id)
AI275695 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 2515 to 2824 310 to 1       310/310
(100 %)
0 diff
(100 %id)
AA503799 colon .e 2516 to 2936 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI660352 thymus, pooled .e 2517 to 2932 423 to 8       416/423
(98 %)
0 diff
(100 %id)
AI278465 placenta .e 2519 to 2936 424 to 7       418/424
(98 %)
0 diff
(100 %id)
AA501997 colon .e 2520 to 2936 417 to 1       417/417
(100 %)
0 diff
(100 %id)
FN147007 breast carcinoma .e 2526 to 2622 95 to 1     Submitted on the opposite strand 95/95
(100 %)
3 diff
(96.9 %id)
W02697 heart .e 2529 to 2936 411 to 1   fully sequenced,   411/411
(100 %)
3 diff
(99.3 %id)
AA749044 germinal center B cell .e 2548 to 2935 406 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 388/388
(100 %)
0 diff
(100 %id)
AA730499 Ewing's sarcoma .e 2558 to 2904 1 to 347       347/347
(100 %)
3 diff
(99.2 %id)
AI273068 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 2559 to 2824 266 to 1       266/266
(100 %)
0 diff
(100 %id)
AA235937.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2573 to 2929 1 to 356     also hits gene zopor 356/356
(100 %)
1 diff
(99.8 %id)
AA814777 germinal center B cell .e 2575 to 2935 379 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 361/361
(100 %)
0 diff
(100 %id)
AA642050   .e 2581 to 2936 369 to 14       356/369
(96 %)
0 diff
(100 %id)
AA644317 lung, lung carcinoma .e 2582 to 2935 383 to 30   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 354/354
(100 %)
0 diff
(100 %id)
AW973881   .e 2583 to 2933 351 to 1     Submitted on the opposite strand 351/351
(100 %)
13 diff
(96.3 %id)
AI089243 uterus .e 2587 to 2942 371 to 16   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 356/356
(100 %)
0 diff
(100 %id)
AA873356 2 pooled tumors (clear cell type), Kidney .e 2602 to 2936 339 to 5       335/339
(98 %)
0 diff
(100 %id)
AA236952.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2606 to 2932 327 to 1     also hits gene C1orf9 327/327
(100 %)
0 diff
(100 %id)
BE672833 Prostate .e 2610 to 2932 329 to 7       323/329
(98 %)
0 diff
(100 %id)
BE673518 Prostate .e 2610 to 2932 329 to 7       323/329
(98 %)
0 diff
(100 %id)
AW674209   .e 2613 to 2935 339 to 17   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 323/323
(100 %)
5 diff
(98.5 %id)
AI378738 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2626 to 2944 320 to 2   tiling clone,   319/320
(99 %)
0 diff
(100 %id)
W81327 heart .e 2641 to 2936 298 to 1   fully sequenced,   298/298
(100 %)
1 diff
(99.7 %id)
W80689 heart .e 2643 to 2935 297 to 1   fully sequenced,   297/297
(100 %)
2 diff
(99.4 %id)
DB517039 testis .e 2677 to 2933 1 to 257     Submitted on the opposite strand 257/258
(99 %)
1 diff
(99.7 %id)
AA173162   .e 2677 to 2942 266 to 1       266/266
(100 %)
0 diff
(100 %id)
T90038 lung .e 2691 to 2932 249 to 7       243/255
(95 %)
0 diff
(100 %id)
AW074335 2 pooled high-grade transitional celltumors, genitourinary tract .e 2726 to 2824 99 to 1       99/99
(100 %)
0 diff
(100 %id)
AA592918 colon, colon tumor RER+ .e 2731 to 2936 212 to 7       206/212
(97 %)
0 diff
(100 %id)
BG676318 skin, squamous cell carcinoma .e 2733 to 2775 772 to 820   AAA   770/1031
(74 %)
22 diff
(97.9 %id)
BM855332 stomach .e 2733 to 2886 1 to 154       154/154
(100 %)
1 diff
(99.4 %id)
C00781   .e 2762 to 2935 1 to 174       174/174
(100 %)
0 diff
(100 %id)
BF908066.
matches multiple genes
uterus_tumor .e 2781 to 2912 10 to 139     also hits gene BTN3A3andBTN2A1 130/139
(93 %)
6 diff
(95.7 %id)
EC545568.
matches multiple genes
Prostate .e 2808 to 2904 6 to 101     also hits gene BTN3A3andBTN2A1 96/101
(95 %)
6 diff
(94.1 %id)
AI933688 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 2852 to 2935 94 to 11   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 84/84
(100 %)
0 diff
(100 %id)
CD686792 normal nasopharynx .f 1 to 565 32 to 596   tiling clone,   565/596
(94 %)
6 diff
(99.0 %id)
NM_007047.3   .f 1 to 3812 1 to 3812 exact RefSeq,   3812/3812
(100 %)
0 diff
(100 %id)
CD703821 normal nasopharynx .f 29 to 588 33 to 591       559/591
(94 %)
7 diff
(98.9 %id)
CD704358 normal nasopharynx .f 29 to 492 39 to 501       463/501
(92 %)
10 diff
(98.1 %id)
DA376713 thalamus .f 30 to 581 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG484826 lung .f 31 to 809 1 to 794       794/797
(99 %)
38 diff
(95.3 %id)
DA840081 placenta .f 33 to 591 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA185860 amygdala .f 34 to 575 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
BG474654 eye, retinoblastoma .f 47 to 903 1 to 869       869/873
(99 %)
30 diff
(96.6 %id)
DA580789   .f 52 to 593 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
BE302631 melanotic melanoma, skin .f 52 to 585 1 to 534       534/534
(100 %)
0 diff
(100 %id)
CD558644 White Matter .f 53 to 679 1 to 633       633/1034
(61 %)
23 diff
(97.8 %id)
AK312847 thymus .f 59 to 1210 1 to 1152       1152/1152
(100 %)
5 diff
(99.6 %id)
DA681280 ovary .f 59 to 618 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
BJ993899 hepatoblastoma .f 60 to 537 1 to 478       478/478
(100 %)
0 diff
(100 %id)
DA916925 small intestine .f 60 to 624 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DB061025 testis .f 60 to 595 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DB158948 thymus .f 60 to 598 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DA132318 alzheimer cortex .f 61 to 608 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA277330 corpus callosum .f 61 to 618 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA978232 synovial membrane tissue from rheumatioidarthritis .f 61 to 613 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB244469 uterus, tumor tissue .f 61 to 633 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
U90546   .f 62 to 1707 1 to 1645 I317S Q318S Y319T L320* AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 1645/1645
(100 %)
1 diff
(100.0 %id)
DA014786 adrenal gland .f 63 to 609 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA333424 hippocampus .f 63 to 671 2 to 611   capped   610/610
(100 %)
1 diff
(99.9 %id)
DA385042 thalamus .f 63 to 626 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
GD152943   .f 63 to 295 233 to 1   AAA Submitted on the opposite strand 233/241
(96 %)
8 diff
(96.7 %id)
DA682294 ovary .f 63 to 623 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA929331 small intestine .f 63 to 626 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA951507 Spleen .f 63 to 637 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA957311 Spleen .f 63 to 626 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA990277 synovial membrane tissue from rheumatioidarthritis .f 63 to 618 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA990946 synovial membrane tissue from rheumatioidarthritis .f 63 to 590 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DA994540 synovial membrane tissue from rheumatioidarthritis .f 63 to 604 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA996032 synovial membrane tissue from rheumatioidarthritis .f 63 to 620 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB133761 thymus .f 63 to 604 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DB188184 liver, tumor tissue .f 63 to 633 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA644302   .f 65 to 631 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA989389 synovial membrane tissue from rheumatioidarthritis .f 66 to 618 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA870607 Prostate .f 67 to 596 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
GD152942   .f 68 to 295 226 to 1     Submitted on the opposite strand 226/229
(98 %)
7 diff
(97.0 %id)
BE390999 endometrium, adenocarcinoma cell line, uterus .f 69 to 567 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BE727189 melanotic melanoma, skin .f 71 to 805 1 to 733       733/734
(99 %)
9 diff
(98.8 %id)
DA959424 Spleen .f 71 to 635 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA828389 placenta .f 72 to 816 2 to 755   capped   752/787
(95 %)
18 diff
(97.8 %id)
DA895000 skeletal muscle .f 73 to 611 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA767648 tongue .f 74 to 643 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CD701513 normal nasopharynx .f 79 to 564 25 to 510       486/510
(95 %)
8 diff
(98.5 %id)
DA385060 thalamus .f 84 to 654 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
TI_57178067   .f 85 to 974 25 to 916   AAA   892/1072
(83 %)
23 diff
(97.9 %id)
BI758777 brain .f 86 to 811 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
TI_57216278   .f 86 to 811 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
CD695877 normal nasopharynx .f 88 to 644 23 to 580       558/580
(96 %)
8 diff
(98.7 %id)
BM313988 insulinoma, Pancreas .f 91 to 624 1 to 534       534/534
(100 %)
6 diff
(98.9 %id)
DN997564 breast cancer, Mammary gland (cancer tissue) .f 91 to 705 1 to 615       615/615
(100 %)
4 diff
(99.4 %id)
BF528053 anaplastic oligodendroglioma with 1p/19qloss, brain .f 92 to 858 1 to 764       764/824
(92 %)
13 diff
(98.5 %id)
BI766909 pooled lung and spleen .f 94 to 974 1 to 884       884/1053
(83 %)
17 diff
(98.4 %id)
BE410597 choriocarcinoma, placenta .f 95 to 727 33 to 665       633/665
(95 %)
7 diff
(99.0 %id)
BC002832 Placenta, choriocarcinoma .f 99 to 1534 1 to 1436 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) 1436/1436
(100 %)
0 diff
(100 %id)
BC020214 Skin, melanotic melanoma, high MDR. .f 99 to 1534 1 to 1436 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) 1436/1436
(100 %)
0 diff
(100 %id)
BE409636 choriocarcinoma, placenta .f 102 to 831 1 to 731       731/777
(94 %)
22 diff
(97.2 %id)
DA932586 Spleen .f 107 to 675 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BE729924 melanotic melanoma, skin .f 119 to 941 1 to 812       812/960
(84 %)
20 diff
(98.0 %id)
U90144   .f 183 to 1708 1 to 1526 exact     1526/1526
(100 %)
4 diff
(99.8 %id)
AA114263 Pancreas .f 187 to 511 1 to 330       330/336
(98 %)
10 diff
(97.1 %id)
BE741523 adenocarcinoma cell line, ovary .f 201 to 964 1 to 759       759/976
(77 %)
11 diff
(98.9 %id)
BE741599 adenocarcinoma cell line, ovary .f 201 to 963 1 to 768       768/919
(83 %)
27 diff
(97.1 %id)
CV026300 mixed .f 256 to 894 1 to 640       640/650
(98 %)
5 diff
(99.3 %id)
BF338725 brain, glioblastoma with EGFR amplification .f 282 to 1062 1 to 772       772/818
(94 %)
18 diff
(97.8 %id)
BQ711172 Spleen .f 316 to 1171 1 to 858       858/952
(90 %)
8 diff
(99.2 %id)
TI_1948121646   .f 399 to 1260 986 to 116       871/1291
(67 %)
29 diff
(97.8 %id)
CD705399 normal nasopharynx .f 422 to 737 30 to 345       316/347
(91 %)
8 diff
(97.7 %id)
TI_1948121510   .f 431 to 1260 946 to 115       832/1273
(65 %)
25 diff
(98.1 %id)
CD700750 normal nasopharynx .f 438 to 1074 31 to 668       638/668
(95 %)
10 diff
(98.6 %id)
TI_1948121797   .f 449 to 1260 954 to 128       827/1346
(61 %)
39 diff
(97.2 %id)
TI_1948121941   .f 520 to 1260 882 to 132       751/1329
(56 %)
46 diff
(96.6 %id)
TI_154126762   .f 625 to 1348 804 to 87   AAA   718/933
(76 %)
11 diff
(98.9 %id)
BI195558 brain, neuroblastoma .f 671 to 1260 1 to 591       591/604
(97 %)
3 diff
(99.6 %id)
AW591602 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 691 to 1111 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AA303854 aorta .f 775 to 1097 1 to 324       324/336
(96 %)
3 diff
(99.2 %id)
BG057291 blood, lymphocyte .f 805 to 1337 536 to 4       533/536
(99 %)
3 diff
(99.5 %id)
AW474467 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 871 to 1542 672 to 1       672/672
(100 %)
13 diff
(98.1 %id)
BF435519 sciatic nerve .f 955 to 1539 588 to 5       584/604
(96 %)
6 diff
(99.1 %id)
AL135445 melanoma (MeWo cell line) .f 958 to 1498 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AW474512 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 967 to 1542 576 to 1       576/576
(100 %)
4 diff
(99.4 %id)
AI269452 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 1081 to 1542 462 to 1       462/465
(99 %)
0 diff
(100 %id)
AW802828 uterus .f 1085 to 1329 245 to 1       245/247
(99 %)
2 diff
(99.2 %id)
BE886943 leiomyosarcoma, uterus .f 1122 to 1798 1 to 685       685/955
(71 %)
10 diff
(99.0 %id)
FN130402 breast carcinoma .f 1127 to 1233 105 to 1     Submitted on the opposite strand 105/105
(100 %)
3 diff
(97.2 %id)
AI039995 senescent fibroblast .f 1138 to 1712 573 to 1       573/573
(100 %)
7 diff
(98.8 %id)
BJ993900 hepatoblastoma .f 1174 to 1676 503 to 1       503/503
(100 %)
0 diff
(100 %id)
BE208673 melanotic melanoma, skin .f 1180 to 1721 542 to 1       542/542
(100 %)
2 diff
(99.7 %id)
BG324070 Kidney, renal cell adenocarcinoma .f 1204 to 1742 1 to 541       541/553
(97 %)
12 diff
(97.9 %id)
DB372901 placenta .f 1208 to 1534 328 to 1       328/356
(92 %)
10 diff
(97.2 %id)
BG324159 Kidney, renal cell adenocarcinoma .f 1214 to 1734 12 to 532       521/729
(71 %)
11 diff
(98.5 %id)
BI001522 head_normal .f 1321 to 1452 1 to 132       132/132
(100 %)
3 diff
(97.8 %id)
AI358431 lymph node, lymphoma, follicular mixed small and largecell .f 1389 to 1718 330 to 1       330/330
(100 %)
4 diff
(98.8 %id)
AW149313 Kidney, renal cell tumor .f 1531 to 1794 264 to 1   tiling clone,   264/264
(100 %)
0 diff
(100 %id)
DB124373 thymus .f 1549 to 2098 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
AA150528 Pancreas .f 1708 to 2095 1 to 395       395/396
(99 %)
9 diff
(97.8 %id)
BF934122 nervous_tumor .f 1709 to 2227 533 to 14     Submitted on the opposite strand 520/533
(97 %)
0 diff
(100 %id)
BI001684 head_normal .f 1717 to 2238 522 to 1       522/565
(92 %)
7 diff
(98.8 %id)
BE693813 breast .f 1723 to 2256 542 to 8       535/542
(98 %)
0 diff
(100 %id)
CD244006 testis .f 1730 to 2419 91 to 791       701/860
(81 %)
19 diff
(97.8 %id)
BI001754 head_normal .f 1733 to 2250 524 to 7       518/524
(98 %)
0 diff
(100 %id)
AU141477 thyroid gland .f 1753 to 2544 2 to 792   tiling clone, capped Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 791/791
(100 %)
3 diff
(99.7 %id)
BG119848 adenocarcinoma, cell line, Liver .f 1754 to 2475 12 to 740       729/921
(79 %)
27 diff
(97.1 %id)
AA356576   .f 1756 to 2104 1 to 353       353/353
(100 %)
8 diff
(97.8 %id)
DA968142 stomach .f 1778 to 2334 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
BQ054495 lymph, lymphoma, cell line .f 1785 to 2707 24 to 949       926/1075
(86 %)
21 diff
(98.1 %id)
CB115516 Liver .f 1792 to 2363 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DB253421 uterus .f 1802 to 2362 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DB102445 thymus .f 1815 to 2363 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
AW858734 colon .f 1835 to 2364 23 to 551       529/560
(94 %)
9 diff
(98.4 %id)
BU162729 large cell carcinoma, lung .f 1856 to 2726 1 to 881       881/889
(99 %)
37 diff
(95.9 %id)
AA336305 endometrium .f 1866 to 2129 1 to 264       264/264
(100 %)
1 diff
(99.7 %id)
BQ682038 melanotic melanoma, cell line, skin .f 1886 to 2782 28 to 938       911/966
(94 %)
37 diff
(96.2 %id)
BC067086 Skin, melanoma, melanotic .f 1936 to 3800 1 to 1865   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 1865/1865
(100 %)
1 diff
(100.0 %id)
BQ677417 melanotic melanoma, cell line, skin .f 1936 to 2871 18 to 954       937/990
(94 %)
34 diff
(96.6 %id)
BQ897005 melanotic melanoma, cell line, skin .f 1937 to 2805 1 to 873       873/873
(100 %)
7 diff
(99.2 %id)
BU168018 melanotic melanoma, cell line, skin .f 1937 to 2787 1 to 853   available from MGC,   853/853
(100 %)
6 diff
(99.3 %id)
BU147315 melanotic melanoma, cell line, skin .f 1937 to 2786 1 to 870       870/933
(93 %)
22 diff
(97.7 %id)
BU145407 melanotic melanoma, cell line, skin .f 1937 to 2609 1 to 678       678/811
(83 %)
10 diff
(98.8 %id)
BQ681361 melanotic melanoma, cell line, skin .f 1937 to 2814 1 to 886       886/898
(98 %)
23 diff
(97.5 %id)
BQ679193 melanotic melanoma, cell line, skin .f 1937 to 2903 1 to 970       970/971
(99 %)
21 diff
(97.9 %id)
BQ683127 melanotic melanoma, cell line, skin .f 1937 to 2858 1 to 925       925/926
(99 %)
25 diff
(97.4 %id)
BQ676799 melanotic melanoma, cell line, skin .f 1937 to 2848 1 to 920       920/922
(99 %)
16 diff
(98.3 %id)
BQ676777 melanotic melanoma, cell line, skin .f 1937 to 2806 1 to 875       875/875
(100 %)
13 diff
(98.6 %id)
BQ679293 melanotic melanoma, cell line, skin .f 1937 to 2874 1 to 939       939/939
(100 %)
22 diff
(97.7 %id)
BQ683662 melanotic melanoma, cell line, skin .f 1937 to 2854 1 to 918       918/918
(100 %)
15 diff
(98.4 %id)
BQ679284 melanotic melanoma, cell line, skin .f 1937 to 2830 1 to 893       893/896
(99 %)
10 diff
(98.9 %id)
BQ679249 melanotic melanoma, cell line, skin .f 1937 to 2643 1 to 714       714/886
(80 %)
16 diff
(98.2 %id)
BQ677172 melanotic melanoma, cell line, skin .f 1937 to 2841 1 to 908       908/916
(99 %)
12 diff
(98.7 %id)
BE741117 adenocarcinoma cell line, ovary .f 1942 to 2756 1 to 811       811/968
(83 %)
16 diff
(98.4 %id)
BF086928 head_neck .f 1959 to 2431 8 to 477       470/477
(98 %)
6 diff
(98.8 %id)
BF571578 melanotic melanoma, high MDR, skin .f 1971 to 2612 634 to 1     Submitted on the opposite strand 634/887
(71 %)
13 diff
(98.6 %id)
AU159029 thyroid gland .f 3279 to 3803 534 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 521/539
(96 %)
9 diff
(98.4 %id)
AK303600 thymus .g 1 to 1231 1 to 1231 M40L N158D S284N tiling clone,   1231/1231
(100 %)
13 diff
(99.0 %id)
DB159987 thymus .g 2 to 576 2 to 576   capped   575/575
(100 %)
7 diff
(98.8 %id)
DA970479 synovial membrane tissue from rheumatioidarthritis .h 1 to 671 2 to 673   tiling clone, capped   672/672
(100 %)
1 diff
(99.9 %id)
DB334638 synovial membrane tissue from rheumatioidarthritis .h 3123 to 3572 448 to 1   tiling clone,   448/456
(98 %)
12 diff
(97.4 %id)
CD705662 normal nasopharynx .i 1 to 526 33 to 558   tiling clone,   526/560
(93 %)
8 diff
(98.6 %id)
DA325137 hippocampus .i 25 to 359 2 to 336   capped   335/335
(100 %)
0 diff
(100 %id)
DA461365 tongue, tumor tissue .i 26 to 589 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AL135422 melanoma (MeWo cell line) .i 42 to 480 1 to 438       438/438
(100 %)
4 diff
(99.1 %id)
BQ706029 Spleen .i 50 to 924 13 to 895   tiling clone,   883/899
(98 %)
19 diff
(97.9 %id)
BQ223277 large cell carcinoma, lung .i 62 to 913 11 to 863       853/863
(98 %)
15 diff
(98.3 %id)
BG390011 embryonal carcinoma, cell line, testis .i 67 to 780 1 to 713       713/713
(100 %)
4 diff
(99.5 %id)
DB152976 thymus .i 71 to 642 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB227325 trachea .i 71 to 644 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA681072 ovary .i 72 to 627 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA951839 Spleen .i 72 to 626 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA993438 synovial membrane tissue from rheumatioidarthritis .i 72 to 627 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
CB131421 Liver .i 73 to 427 1 to 355       355/355
(100 %)
0 diff
(100 %id)
DA923755 small intestine .i 74 to 597 2 to 525   capped   524/529
(99 %)
4 diff
(99.3 %id)
DA993351 synovial membrane tissue from rheumatioidarthritis .i 74 to 601 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DA945111 Spleen .i 91 to 634 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA993422 synovial membrane tissue from rheumatioidarthritis .i 91 to 638 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA564483 heart .i 96 to 634 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
BG755834 B-cells, primary B-cells from tonsils (cell line) .i 99 to 882 1 to 789       789/947
(83 %)
28 diff
(97.1 %id)
BG823547 adenocarcinoma cell line, colon .i 105 to 950 1 to 860       803/943
(85 %)
45 diff
(95.3 %id)
AK299417 tongue .i 117 to 1628 1 to 1512 A140T tiling clone,   1512/1512
(100 %)
4 diff
(99.8 %id)
BE275413 melanotic melanoma, skin .i 118 to 794 1 to 678       678/678
(100 %)
12 diff
(98.3 %id)
DA763977 tongue .i 118 to 687 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB111516 thymus .i 118 to 685 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
CB117271 Liver .i 119 to 573 1 to 455       455/455
(100 %)
0 diff
(100 %id)
DB192338 ovary, tumor tissue .i 120 to 670 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA005923   .i 121 to 626 2 to 508   capped   507/507
(100 %)
2 diff
(99.7 %id)
BM153016 leukopheresis .i 121 to 408 1 to 289       289/289
(100 %)
13 diff
(95.6 %id)
DA838773 placenta .i 123 to 671 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BG469837 adenocarcinoma cell line, colon .i 133 to 882 1 to 782       689/788
(87 %)
45 diff
(94.3 %id)
BF172538 blood .i 150 to 274 1 to 125       125/125
(100 %)
4 diff
(96.8 %id)
BF794581 lymph, lymphoma, cell line .j 1 to 807 1 to 802   tiling clone,   802/853
(94 %)
19 diff
(97.8 %id)
CB958721 Pooled-Glandular .j 520 to 1136 1 to 627   tiling clone,   627/757
(82 %)
27 diff
(96.5 %id)
AW151752 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 564 to 905 342 to 1       342/342
(100 %)
5 diff
(98.6 %id)
BQ883584 Spleen .k 1 to 680 1 to 692   tiling clone,   692/925
(74 %)
32 diff
(96.6 %id)
BI767786 pooled lung and spleen .k 36 to 874 1 to 837   tiling clone,   837/839
(99 %)
8 diff
(99.1 %id)
TI_57183794   .k 36 to 874 35 to 871       837/873
(95 %)
14 diff
(98.4 %id)
TI_149294209   .k 540 to 1276 796 to 50   tiling clone,   747/797
(93 %)
4 diff
(99.5 %id)
AW519250 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k 740 to 1248 506 to 1   tiling clone,   506/506
(100 %)
12 diff
(97.7 %id)
AA506904 Prostate .k 990 to 1260 271 to 1       271/278
(97 %)
1 diff
(99.7 %id)
DB145504 thymus .l 1 to 514 2 to 516   tiling clone, capped   515/515
(100 %)
1 diff
(99.9 %id)
DB345713 thymus .l 3216 to 3747 532 to 1   tiling clone,   532/532
(100 %)
0 diff
(100 %id)
DA431612 colon .m 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA426422 colon .m 34 to 592 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AU077015   .m 35 to 287 1 to 253       253/253
(100 %)
0 diff
(100 %id)
DA994886 synovial membrane tissue from rheumatioidarthritis .m 36 to 582 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DB277810 uterus .m 36 to 577 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BE789093 large cell carcinoma, lung .m 67 to 762 1 to 691   tiling clone,   691/699
(98 %)
8 diff
(98.9 %id)
BG392921 embryonal carcinoma, cell line, testis .m 81 to 632 1 to 552       552/552
(100 %)
2 diff
(99.7 %id)
AA134341 colon, tumor .m 679 to 883 1 to 206   tiling clone,   206/207
(99 %)
3 diff
(98.6 %id)
AW363565 colon .m 685 to 1120 34 to 473       440/479
(91 %)
12 diff
(97.5 %id)
AI811836 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 688 to 1329 641 to 1       641/641
(100 %)
23 diff
(96.5 %id)
CA442970 Fibrosarcoma .m 712 to 1509 793 to 1   tiling clone,   793/795
(99 %)
5 diff
(99.4 %id)
AI538590 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 832 to 1332 502 to 1       502/502
(100 %)
12 diff
(97.7 %id)
AA134342 colon, tumor .m 1077 to 1475 414 to 1       414/445
(93 %)
14 diff
(96.9 %id)
DB451571 testis .n 1 to 496 1 to 496   tiling clone,   496/496
(100 %)
1 diff
(99.8 %id)
BF591580 brain, glioblastoma (pooled) .n 727 to 1206 480 to 1   tiling clone,   480/480
(100 %)
6 diff
(98.8 %id)
AA888172 2 pooled tumors (clear cell type), Kidney .n 973 to 1204 245 to 14   tiling clone, AAA   232/232
(100 %)
0 diff
(100 %id)
BG434522 placenta .n 1044 to 1204 1 to 161   AAA   161/161
(100 %)
1 diff
(99.4 %id)
CD704480 normal nasopharynx .o 1 to 135 41 to 175   tiling clone,   135/175
(77 %)
6 diff
(96.6 %id)
DA991689 synovial membrane tissue from rheumatioidarthritis .o 5 to 540 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DB222332 trachea .o 5 to 596 2 to 594   tiling clone, capped   593/593
(100 %)
2 diff
(99.7 %id)
DA852160 placenta .o 14 to 543 8 to 537   tiling clone, capped   530/530
(100 %)
0 diff
(100 %id)
TI_154009233   .o 544 to 1233 817 to 120   tiling clone, AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 698/742
(94 %)
17 diff
(97.8 %id)
CA435220 lung, Metastatic Chondrosarcoma .o 655 to 1248 594 to 1   tiling clone,   594/594
(100 %)
1 diff
(99.9 %id)
BE247486 leukopheresis .p-u 1 to 307 1 to 308   tiling clone,   308/312
(98 %)
6 diff
(98.1 %id)
DA313497 hippocampus .p-u 10 to 559 2 to 549 Y61H M62V C63Y T64M A66T ... tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
CA405439 adipose .p-u 65 to 303 1 to 240       240/240
(100 %)
1 diff
(99.6 %id)
AW370362 breast .q-u 1 to 626 1 to 625 M8* tiling clone,   625/625
(100 %)
4 diff
(99.4 %id)
AW809101 stomach .q-u 292 to 922 641 to 14   tiling clone,   628/667
(94 %)
15 diff
(97.8 %id)
DA952998 Spleen .r 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
DB163842 thymus .r 26 to 612 2 to 588 exact capped   587/587
(100 %)
2 diff
(99.7 %id)
DA944279 Spleen .r 31 to 587 2 to 559 W11X N12E V15G T17D L18T ... capped   558/558
(100 %)
1 diff
(99.9 %id)
DB121283 thymus .r 31 to 591 2 to 562 exact capped   561/561
(100 %)
0 diff
(100 %id)
BQ711888 Spleen .r 38 to 923 11 to 897 exact tiling clone,   887/897
(98 %)
11 diff
(98.8 %id)
DA916951 small intestine .r 60 to 624 2 to 567 W11X N12E V15G T17D L18T ... capped   566/566
(100 %)
1 diff
(99.9 %id)
DA939594 Spleen .r 60 to 645 2 to 587 exact capped   586/586
(100 %)
0 diff
(100 %id)
DB148335 thymus .r 62 to 618 2 to 558 exact capped   557/557
(100 %)
0 diff
(100 %id)
DB129662 thymus .r 66 to 610 2 to 546 exact capped   545/545
(100 %)
0 diff
(100 %id)
DA363341 subthalamic nucleus .r 73 to 634 2 to 563 exact capped   562/562
(100 %)
0 diff
(100 %id)
DA936383 Spleen .r 73 to 669 2 to 598 exact capped   597/597
(100 %)
0 diff
(100 %id)
AA309452   .r 112 to 359 1 to 252 exact     252/252
(100 %)
4 diff
(98.5 %id)
DA949671 Spleen .r 300 to 678 2 to 380   capped   379/379
(100 %)
0 diff
(100 %id)
DA936019 Spleen .s 1 to 691 2 to 602 exact tiling clone, capped   601/601
(100 %)
0 diff
(100 %id)
AA703377 liver and spleen .s 391 to 889 493 to 1       493/495
(99 %)
8 diff
(98.4 %id)
AI247679 liver and spleen .s 397 to 894 497 to 1       497/500
(99 %)
16 diff
(96.8 %id)
AI033154 liver and spleen .s 414 to 889 476 to 1       476/477
(99 %)
6 diff
(98.8 %id)
AI248047 liver and spleen .s 428 to 905 477 to 1   tiling clone,   477/477
(100 %)
4 diff
(99.2 %id)
AI248605 liver and spleen .s 428 to 894 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
DB124787 thymus .t 1 to 550 2 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
DA381251 thalamus .t 50 to 594 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA950368 Spleen .t 66 to 638 2 to 574 exact tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DN998178 breast cancer, Mammary gland (cancer tissue) .u 1 to 582 1 to 581 exact tiling clone,   581/581
(100 %)
5 diff
(99.2 %id)
DA358553 subthalamic nucleus .va 1 to 484 2 to 485 exact tiling clone, capped   484/484
(100 %)
1 diff
(99.8 %id)
DA358600 subthalamic nucleus .va 1 to 313 2 to 316   capped   315/315
(100 %)
2 diff
(99.4 %id)
AW579242 denis_drash .vb 1 to 420 22 to 441 K2Q G3R E4D N5D tiling clone,   420/441
(95 %)
6 diff
(98.7 %id)
AW002061 thymus, pooled Gene BTN3A2, variant not shown         Submitted on the opposite strand    
F23206 pectoral muscle (after mastectomy) Gene BTN3A2, variant not shown              
DA967153 stomach Gene BTN3A2, variant not shown       capped      
DB334531 stomach Gene BTN3A2, variant not shown              
BE244271 leukopheresis Gene BTN3A2, variant not shown              
BE247089 leukopheresis Gene BTN3A2, variant not shown              
70 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q-u, .r, .s, .t, .u, .va, .vb Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC